Àngels Arcusa

1.9k total citations
34 papers, 1.0k citations indexed

About

Àngels Arcusa is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Àngels Arcusa has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Àngels Arcusa's work include Breast Cancer Treatment Studies (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Treatment and Pharmacology (6 papers). Àngels Arcusa is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Treatment and Pharmacology (6 papers). Àngels Arcusa collaborates with scholars based in Spain, United States and France. Àngels Arcusa's co-authors include E. Batiste-Alentorn, Miguel Ángel Seguí, Jaume Boadas, Joan Maurel, Salvadora Delgado, Xavier Bessa, Joan Saló, Virgı́nia Piñol, Antonio M. Lacy and Josep M. Piqué and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Àngels Arcusa

33 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Àngels Arcusa Spain 16 616 302 234 156 145 34 1.0k
Margot J. Burnell Canada 12 649 1.1× 254 0.8× 420 1.8× 100 0.6× 141 1.0× 32 1.1k
Peter Klare Germany 19 754 1.2× 372 1.2× 207 0.9× 340 2.2× 86 0.6× 89 1.3k
J Robert Canada 9 586 1.0× 194 0.6× 445 1.9× 108 0.7× 120 0.8× 16 955
Danielle Desautels Canada 10 562 0.9× 136 0.5× 152 0.6× 87 0.6× 46 0.3× 28 814
Jeffrey P. Meyers United States 17 863 1.4× 408 1.4× 203 0.9× 528 3.4× 317 2.2× 40 1.4k
Weiwei Feng China 18 240 0.4× 90 0.3× 337 1.4× 66 0.4× 89 0.6× 38 1.3k
Seraina Schmid Switzerland 16 342 0.6× 119 0.4× 419 1.8× 153 1.0× 123 0.8× 48 972
J P Droz France 17 193 0.3× 397 1.3× 67 0.3× 838 5.4× 58 0.4× 33 1.3k
Enora Laas France 21 585 0.9× 184 0.6× 350 1.5× 181 1.2× 116 0.8× 97 1.5k
D.B.Y. Fontein Netherlands 16 454 0.7× 210 0.7× 254 1.1× 246 1.6× 98 0.7× 29 767

Countries citing papers authored by Àngels Arcusa

Since Specialization
Citations

This map shows the geographic impact of Àngels Arcusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Àngels Arcusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Àngels Arcusa more than expected).

Fields of papers citing papers by Àngels Arcusa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Àngels Arcusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Àngels Arcusa. The network helps show where Àngels Arcusa may publish in the future.

Co-authorship network of co-authors of Àngels Arcusa

This figure shows the co-authorship network connecting the top 25 collaborators of Àngels Arcusa. A scholar is included among the top collaborators of Àngels Arcusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Àngels Arcusa. Àngels Arcusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribelles, Nuria, Isabel Álvarez, Àngels Arcusa, et al.. (2021). Electronic health records and patient registries in medical oncology departments in Spain. Clinical & Translational Oncology. 23(10). 2099–2108. 3 indexed citations
2.
Romero, Ignacio, Ana Santaballa, Santiago González-Santiago, et al.. (2019). Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer. Anti-Cancer Drugs. 30(6). 628–635. 9 indexed citations
3.
Cerulla, Noemí, et al.. (2017). Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study. Breast Cancer Research and Treatment. 164(1). 179–187. 23 indexed citations
4.
Hernán, Imma, Emma Borràs, Miguel Dias, et al.. (2015). Two novel frameshift mutations in BRCA2 gene detected by next generation sequencing in a survey of Spanish patients of breast cancer. Clinical & Translational Oncology. 17(7). 576–580. 3 indexed citations
5.
Martín, Miguel, Milagros González‐Rivera, Serafín Morales, et al.. (2015). Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study. Cancer Research. 75(9_Supplement). P6–8. 3 indexed citations
6.
Bonet, Marta, Pere Godoy, M. Algara, et al.. (2014). Are breast cancer patients treated with radiotherapy younger now than ten years ago?. Reports of Practical Oncology & Radiotherapy. 20(1). 22–26. 1 indexed citations
7.
Borràs, Emma, E. Dotor, Àngels Arcusa, et al.. (2013). High-resolution melting analysis of the common c.1905+1G>A mutation causing dihydropyrimidine dehydrogenase deficiency and lethal 5-fluorouracil toxicity. Frontiers in Genetics. 3. 312–312. 10 indexed citations
8.
Casas, Francesc, Esther Jovell, Remei Blanco, et al.. (2012). Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status. Clinical & Translational Oncology. 14(1). 66–72. 21 indexed citations
9.
Font, Rebeca, Josep Alfons Espinàs, Miguel Gil‐Gil, et al.. (2012). Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain. British Journal of Cancer. 107(8). 1249–1256. 64 indexed citations
10.
Borràs, Emma, Imma Hernán, María José Gamundi, et al.. (2011). Clinical pharmacogenomic testing of KRAS, BRAF and EGFRmutations by high resolution melting analysis and ultra-deep pyrosequencing. BMC Cancer. 11(1). 406–406. 68 indexed citations
11.
Barnadas, Agustí, Sónia González, Ignasi Tusquets, et al.. (2009). Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial. British Journal of Cancer. 100(3). 442–449. 30 indexed citations
12.
Seguí, Miguel Ángel, Xavier Andreu, E. Dalmau, et al.. (2007). Analysis of the Pathologic Response to Primary Chemotherapy in Patients with Locally Advanced Breast Cancer Grouped According to Estrogen Receptor, Progesterone Receptor, and HER2 Status. Clinical Breast Cancer. 7(7). 559–564. 29 indexed citations
13.
14.
González-Martı́n, Antonio, Isabel Bover, María Jesús Rubio, et al.. (2005). Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study. Annals of Oncology. 16(5). 749–755. 90 indexed citations
15.
Salud, Antonieta, E. Batiste-Alentorn, Eugeni Saigí, et al.. (2005). Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer. European Journal of Cancer. 41(15). 2241–2249. 9 indexed citations
16.
17.
18.
Cirera, Lluís, Àngels Arcusa, E. Batiste-Alentorn, et al.. (2002). Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer. Anti-Cancer Drugs. 13(8). 839–845. 21 indexed citations
19.
Cirera, Luis, A. Balil, E. Batiste-Alentorn, et al.. (1999). Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer. Journal of Clinical Oncology. 17(12). 3810–3815. 88 indexed citations
20.
Seguí, Miguel Ángel, et al.. (1998). Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma. Cancer. 83(2). 254–258. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margot J. Burnell Breakdown of academic impact, for papers by Peter Klare Breakdown of academic impact, for papers by J Robert Breakdown of academic impact, for papers by Danielle Desautels Breakdown of academic impact, for papers by Jeffrey P. Meyers Breakdown of academic impact, for papers by Weiwei Feng Breakdown of academic impact, for papers by Seraina Schmid Breakdown of academic impact, for papers by J P Droz Breakdown of academic impact, for papers by Enora Laas Breakdown of academic impact, for papers by D.B.Y. Fontein
Rankless by CCL
2026